Mutational analysis of patients with FGF23-related hypophosphatemic rickets
Yuka Kinoshita(University of Tokyo Hospital), Toshiro Fujita(The University of Tokyo), Takashi Igarashi(National Center For Child Health and Development), Manabu Taguchi(The University of Tokyo), T. Saito(University of Tokyo Hospital), Seiji Fukumoto(Tokushima Hospital), Michiko Hori(University of Tokyo Hospital), Yuichiro Shimizu(Shimizu (Japan))
Cited by 38
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
|BMC Nephrology|2016|209
IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na <sup>+</sup> /HCO <sub>3</sub> <sup>−</sup> cotransporter 1 (pNBC1)
|Proceedings of the National Academy of Sciences|2006|173
Defective membrane expression of the Na <sup>+</sup> -HCO <sub>3</sub> <sup>−</sup> cotransporter NBCe1 is associated with familial migraine
|Proceedings of the National Academy of Sciences|2010|152
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
|Endocrine Reviews|2018|148